arrow
R

Ruth Link-Gelles

Centers for Disease Control and Prevention
H指数:48
被引数:9,159

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023-March 2024

相关性疫苗接种行为对老年人COVID-19疫苗有效性估计的影响——VISION网络,2023年10月至2024年3月

Vaccine
IF3.5
2026-07-010
PRE
Effectiveness of Bivalent mRNA COVID-19 Vaccine Among Adults With Kidney Failure Receiving Dialysis: A Cohort Study From the Centers for Medicare and Medicaid Services

双价mRNA COVID-19疫苗在肾功能衰竭并接受透析的成人中的有效性:一项来自Centers for Medicare and Medicaid Services的队列研究

2025-09-190
PRE
Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023–March 2024: a test-negative design analysis

2023年10月至2024年3月美国首次RSV流行季中,尼瑞韦玛姆在婴儿中的有效性:一项测试阴性设计分析

2025-08-060
PRE
Patterns in Prescribing and Dispensing Influenza Antivirals Among Adults With Influenza Presenting to Urgent Care and Emergency Department Settings: VISION Network, 2023-2024
2025-04-010
PRE
A framework for monitoring RSV prevention product effectiveness in the United States

一个用于监测美国RSV预防产品有效性的框架

VACCINE
IF3.5
2025-01-010
PRE
Influenza Vaccine Effectiveness Against Hospitalizations and Emergency Department or Urgent Care Encounters for Children, Adolescents, and Adults During the 2023-2024 Season, United States
2024-12-041
PRE
Effectiveness of the Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters in Pregnant Persons Who Were Not Immunocompromised: VISION Network, June 2022-August 2023

原始单价和二价新型冠状病毒肺炎疫苗对未免疫受损的孕妇COVID-19-Associated急诊科和紧急护理的有效性: 视觉网络,2022年6月-2023年8月

2024-08-280
OA
Risk of COVID-19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric Disorders
2024-03-170
OA
Effectiveness of the Original Monovalent Coronavirus Disease 2019 Vaccines in Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Adults With Disabilities: VISION Network, June 2021-September 2022
2023-09-292
OA
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With Coronavirus Disease 2019-VISION Network, 10 States, June 2021-March 2023
2023-08-2613
OA
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions-VISION Network, September 2022-April 2023
2023-07-016
PRE
Effectiveness of Booster Doses of Monovalent mRNA COVID-19 Vaccine Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children, Adolescents, and Adults During Omicron Subvariant BA.2/BA.2.12.1 and BA.4/BA.5 Predominant Periods
2023-04-139
OA
Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents
2023-04-078
PRE
Relative Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccination and Booster Dose Combinations Among 18.9 Million Vaccinated Adults During the Early Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Period-United States, 1 January 2022 to 31 March 2022
2023-02-0811
OA